Cite
APA Citation
Largeaud, L., Bérard, E., Bertoli, S., Dufrechou, S., Prade, N., Gadaud, N., Tavitian, S., Bories, P., Luquet, I., Sarry, A., De Mas, V., Huguet, F., Delabesse, E., & Récher, C. (2019). outcome of AML patients with IDH2 mutations in real world before the era of IDH2 inhibitors. Leukemia research, 81, 82–87. http://access.bl.uk/ark:/81055/vdc_100083741173.0x000051